Inventor
GILLESPIE ROGER JOHN
GB32 patents
⚠️ This page may combine multiple inventors who share the name “GILLESPIE ROGER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERNALIS RES LTD
16 patentsUS6787541B1Sep 7, 2004
Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
VERNALIS RES LTD64 citations95
US7405219B2Jul 29, 2008
Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
VERNALIS RES LTD44 citations94
US7141575B2Nov 28, 2006
Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
VERNALIS RES LTD45 citations94
US6608085B1Aug 19, 2003
4-quinolinemethanol derivatives as purine receptor antagonists (II)
VERNALIS RES LTD55 citations91
US7589097B2Sep 15, 2009
Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists
VERNALIS RES LTD18 citations90
US6828318B2Dec 7, 2004
2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
VERNALIS RES LTD48 citations89
US6583156B1Jun 24, 2003
4-Quinolinemethanol derivatives as purine receptor antagonists (1)
VERNALIS RES LTD33 citations89
US7384949B2Jun 10, 2008
Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists
VERNALIS RES LTD10 citations82
US7629349B2Dec 8, 2009
Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists
VERNALIS RES LTD4 citations62
US7098333B2Aug 29, 2006
Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists
VERNALIS RES LTD2 citations62
US7087754B2Aug 8, 2006
Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists
VERNALIS RES LTD5 citations62
US7452894B2Nov 18, 2008
Purine derivatives as purinergic receptor antagonists
VERNALIS RES LTD2 citations60
US6531511B1Mar 11, 2003
2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
VERNALIS RES LTD2 citations58
US6262106B1Jul 17, 2001
Adamantanecarboximidamide derivatives and their use as NMDA antagonists
VERNALIS RES LTD3 citations57
US6500866B1Dec 31, 2002
1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
VERNALIS RES LTD2 citations56
US7598256B2Oct 6, 2009
Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists
VERNALIS RES LTD0 citations51
VERNALIS R&D LTD
8 patentsUS8987279B2Mar 24, 2015
Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD40 citations97
US9765080B2Sep 19, 2017
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD9 citations92
US9376443B2Jun 28, 2016
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD11 citations92
US11466019B2Oct 11, 2022
Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD0 citations62
US7875600B2Jan 25, 2011
Pyrimidine compounds as purine receptor antagonist
VERNALIS R&D LTD2 citations60
US10875868B2Dec 29, 2020
Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD0 citations51
US10538526B2Jan 21, 2020
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD0 citations51
US10106547B2Oct 23, 2018
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
VERNALIS R&D LTD0 citations51
VERTEX PHARMA
6 patentsUS5874424AFeb 23, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA141 citations98
US6423840B1Jul 23, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA40 citations96
US6258948B1Jul 10, 2001
Inhibitors of Interleukin-1β converting enzyme
VERTEX PHARMA42 citations96
US6204261B1Mar 20, 2001
Inhibitors of interleukin-1β Converting enzyme inhibitors
VERTEX PHARMA80 citations96
US7790713B2Sep 7, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations92
US6008217ADec 28, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA37 citations92